Webinar: The biomarker calprotectin - for plasma and serum

30. Nov 2021 | 5 min read

Webinar: The biomarker calprotectin - for plasma and serum

Biomarker for early detection of the inflammatory response to infections

Calprotectin is one of the earliest biomarkers for detection of the inflammatory response to infections1,2. The biomarker is predominantly expressed in neutrophil granulocytes, and it is released upon neutrophil activation in response to inflammation and infection. 

Calprotectin in plasma and serum can be a valuable biomarker in different areas:

  • discrimination between bacterial and viral infection3 
  • assessment of severe infections and sepsis2,4,5
  • prediction for development of severe infections6
  • a risk marker in severe COVID-197,8
  • for non-infectious inflammatory diseases, like rheumatic diseases9

 

Watch webinar: The biomarker calprotectin to learn more

 

The biomarker calprotectin_9154v01


Get in touch for information and ordering

Interested in calprotectin for plasma and serum? Want to know more? Please send an email to marketing@gentian.com or fill out the form below:

 

 

plasma and serum calprotectin

 

References:

  1. Fullerton J et al. Kinetics of calprotectin, procalcitonin and C-reactive protein in healthy volunteers administered intravenous endotoxin. 40th International Symposium on Intensive Care & Emergency Medicine. Critical Care. 2020. P474.

  2. Jonsson N et al. Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessmentCrit Care Resusc. 2017.
  3. Havelka A et al. Calprotectin, a new biomarker for diagnosis of acute respiratory infections. Sci Rep. 2020.
  4. Larsson A et al. Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patientsScand J Clin Lab Invest. 2020.
  5. Simm M et al. Performance of plasma calprotectin as a biomarker of early sepsis: a pilot studyBiomark Med. 2016.
  6. Parke Å et al. Plasma-calprotectin compared with routine biomarkers for prediction of early severe event in sepsis. 40th International Symposium on Intensive Care & Emergency Medicine. Critical Care. 2020.
  7. Bauer W et al. Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency departmentJ Infect. 2021.
  8. Luis García de Guadiana Romualdo et al. Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case seriesJ Infect. 2021.
  9. Ometto F et al. Calprotectin in rheumatic diseasesExp Biol Med (Maywood). 2017.

You may also read


COVID-19 and calprotectin's clinical value

Dec 21, 2021

COVID-19 and calprotectin's clinical value

Calprotectin as a valuable prognostic marker in care of COVID-19 patients The rising numbers of SARS-CoV-2..

Webinar: SARS-CoV-2 Total Antibody Immunoassay - Launch soon

Dec 01, 2021

Webinar: SARS-CoV-2 Total Antibody Immunoassay - Launch soon

SARS-CoV-2 Total Antibody Immunoassay - Soon on chemical analysers In the effort to restrain the COVID-19..

Webinar: The biomarker calprotectin - for plasma and serum

Nov 30, 2021

Webinar: The biomarker calprotectin - for plasma and serum

Biomarker for early detection of the inflammatory response to infections Calprotectin is one of the earliest..